ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

NEJM Papers Reaffirm Results Of Lumpectomy Trial; Audit Verifies Data

December 8, 1995

Diet, Nutrition Committee To Rate Suggested Projects

January 9, 1976

Soybean Studies, Computing Support Recompetition Ok’d

November 9, 1990